EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Huanggan decoction ameliorates cholestatic hepatic fibrosis in rats via TGF-β1/Smad3 signaling pathway

Yaya Lei iD, Xueli Ma, Xiaohui Jin, Yanping He, Jianhong Yang, Yuna Zhao, Jing Chen, Ting Gao

PLOS One · 04.03.2026 · 21 (3) · e0344168

DOI: 10.1371/journal.pone.0344168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 04.03.2026. Verfasst von Yaya Lei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Preparation, General Hospital of Ningxia Medical University, Yinchuan, China. Hauptthemen laut MEDLINE: Transforming Growth Factor beta1, Liver Cirrhosis, Signal Transduction, Smad3 Protein. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Ningxia Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Huanggan Decoction (HGD), as a special Chinese medicine preparation, has good effects in clearing heat, removing dampness, eliminating jaundice. HGD has been used in medical institutions for more than 40 years, and shows an outstanding curative effect in jaundice and cholestatic liver diseases (CLD), makes up for the deficiency of the treatment of CLD. However, the underlying mechanisms of HGD for its therapeutic effects are still not well understood.

Methods

The hepatoprotective properties of HGD were assessed using a cholestatic liver fibrosis (CLF) rat model induced by ANIT. Serum liver function index was analyzed by automatic chemical analyzer. Serum biomarkers of liver fibrosis and inflammatory factors were detected by ELISA kits. Liver pathology and collagen fiber extent were assessed using HE and Masson’s stains. Expressions of pro-fibrotic cytokine TGF-β1 and the indicator of HSC activation α-SMA in liver were assayed by immunohistochemistry. The levels of Smad3, phosphorylated Smad3, MMP1 and TIMP1 were assayed by western blotting.

Results

HGD dramatically decreased the serum biochemical indexes, down-regulated the serum biomarkers of liver fibrosis and inflammatory cytokines, reduced the collagen deposition, ameliorated pathological damage. At the same time, HGD notably reduced the level of α-SMA. Additionally, HGD increased MMP1 protein level while decreasing TIMP1 protein level and the p-Smad3 to Smad3 ratio.

Conclusions

Findings suggest that HGD demonstrated a remarkable liver-protective effect, potentially linked to halting liver fibrosis progression by maintaining the equilibrium between MMP1 and TIMP1, modulating TGF-β1/Smad signal pathway, suppressing HSC activation, and exhibiting anti-inflammatory characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor beta1Liver CirrhosisSignal TransductionSmad3 ProteinDrugs, Chinese HerbalCholestasisAnimalsMaleRatsTissue Inhibitor of Metalloproteinase-1LiverRats, Sprague-DawleyMatrix Metalloproteinase 1

Substanzen

Transforming Growth Factor beta1Smad3 ProteinDrugs, Chinese HerbalTissue Inhibitor of Metalloproteinase-1Smad3 protein, ratMatrix Metalloproteinase 1

Autor:innen und Institutionen

  • Department of Pharmaceutical Preparation, General Hospital of Ningxia Medical University, Yinchuan, China.
  • Department of Obstetrics, General Hospital of Ningxia Medical University, Yinchuan, China.
  • Science and Technology Research Center, Ningxia Medical University, Yinchuan, China School of Basic Medicine, Ningxia Medical University, Yinchuan, China.
  • College of Pharmacy, Ningxia Medical University, Yinchuan, China.

ORCID-Profile: Yaya Lei

Förderung

  • Natural Science Foundation of Ningxia Province

Zitieren

APA

Lei, Y., Ma, X., Jin, X., He, Y., Yang, J., Zhao, Y., Chen, J., & Gao, T. (2026). Huanggan decoction ameliorates cholestatic hepatic fibrosis in rats via TGF-β1/Smad3 signaling pathway. PLOS One, 21(3), e0344168. https://doi.org/10.1371/journal.pone.0344168

Vancouver

Lei Y, Ma X, Jin X, He Y, Yang J, Zhao Y, et al. Huanggan decoction ameliorates cholestatic hepatic fibrosis in rats via TGF-β1/Smad3 signaling pathway. PLOS One. 2026;21(3):e0344168. doi:10.1371/journal.pone.0344168

BibTeX
@article{Lei2026,
  author = {Lei, Yaya and Ma, Xueli and Jin, Xiaohui and He, Yanping and Yang, Jianhong and Zhao, Yuna and Chen, Jing and Gao, Ting},
  title = {Huanggan decoction ameliorates cholestatic hepatic fibrosis in rats via TGF-β1/Smad3 signaling pathway},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0344168},
  doi = {10.1371/journal.pone.0344168}
}
Kostenlos starten →